S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q2 2025

RA Capital Management

Period: Q2 2025 Β· Filed: 2025-08-14
View on SEC EDGAR β†—
AUM
$5.94B
Total portfolio value
Positions
63
Reported securities
Top Holding
ASND
29.9% $1.77B
QoQ Changes
+6 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S - ADR$1.77B29.90%$172.60$274.50+59.0%
29.9%
PCVXVAXCYTE INC$389.0M6.55%$32.51$58.39+79.6%
6.5%
RYTMRHYTHM PHARMACEUTICALS INC$351.4M5.92%$63.19$114.17+80.7%
5.9%
JANXJANUX THERAPEUTICS INC$258.5M4.35%$23.10$15.54-32.7%
4.3%
RNAMAVIDITY BIOSCIENCES INC$206.4M3.48%β€”β€”
3.5%
ACLXARCELLX INC$200.0M3.37%$65.85β€”
3.4%
ETNB89BIO INC$195.3M3.29%β€”β€”
3.3%
SPRYARS PHARMACEUTICALS INC$189.5M3.19%$17.45$8.56-51.0%
3.2%
NAMSNEWAMSTERDAM PHARMA CO NV$183.6M3.09%$18.11$34.83+92.3%
3.1%
SIONSIONNA THERAPEUTICS INC$181.2M3.05%$17.35$43.99+153.5%
3.0%
CDTXCIDARA THERAPEUTICS INC$163.9M2.76%β€”β€”
2.8%
EWTXEDGEWISE THERAPEUTICS INC$129.8M2.19%$13.11$39.56+201.8%
2.2%
LENZLENZ THERAPEUTICS INC$122.5M2.06%$29.31$5.89-79.9%
2.1%
WVEWAVE LIFE SCIENCES LTD$118.3M1.99%$6.50$6.26-3.7%
2.0%
TYRATYRA BIOSCIENCES INC$116.7M1.97%$9.57$30.62+220.0%
2.0%
GHRSGH RESEARCH PLC$93.6M1.58%$12.19$27.01+121.6%
1.6%
DYNDYNE THERAPEUTICS INC$92.5M1.56%$9.52$23.07+142.3%
1.6%
GERNGERON CORP$85.1M1.43%$1.41$1.36-3.5%
1.4%
IRONDISC MEDICINE INC$83.5M1.41%$52.96$76.26+44.0%
1.4%
MLYSMINERALYS THERAPEUTICS INC$83.2M1.40%$13.53$27.69+104.7%
1.4%
SEPNSEPTERNA INC$74.0M1.25%$10.57$34.00+221.7%
1.3%
FULCFULCRUM THERAPEUTICS INC$70.4M1.19%$6.88$3.84-44.2%
1.2%
BCAXBICARA THERAPEUTICS INC$64.6M1.09%$9.29$29.00+212.2%
1.1%
VORXXXXVOR BIOPHARMA INC$64.2M1.08%β€”β€”
1.1%
TSHATAYSHA GENE THERAPIES INC$54.4M0.92%$2.31$6.53+182.7%
0.9%
DNTHDIANTHUS THERAPEUTICS INC$53.4M0.90%$18.63$94.34+406.4%
0.9%
RXSTRXSIGHT INC$48.1M0.81%$13.00$5.61-56.9%
0.8%
TRMLTOURMALINE BIO INC$40.6M0.68%β€”β€”
0.7%
SRRKSCHOLAR ROCK HOLDING CORP$40.3M0.68%$35.42$54.88+54.9%
0.7%
CLYMCLIMB BIO INC$39.0M0.66%$1.24$12.90+940.3%
0.7%

Quarter-on-Quarter Activity

Q2 2025 vs. Q1 2025

New Positions (6)

TickerIssuerNotional
HNGEHINGE HEALTH INC-A$15.5M
JBIOJADE BIOSCIENCES INC$10.6M
TNGXTANGO THERAPEUTICS INC$10.2M
OMDAOMADA HEALTH INC$7.3M
WGSGENEDX HOLDINGS CORP$5.4M
IFRXINFLARX NV$1.6M

Exited Positions (8)

TickerIssuerNotional
APGEAPOGEE THERAPEUTICS INC$58.6M
ZLABZAI LAB LTD-ADR$46.8M
DAWNDAY ONE BIOPHARMACEUTICALS I$45.6M
URGNUROGEN PHARMA LTD$35.5M
ATXSASTRIA THERAPEUTICS INC$27.3M
KURAKURA ONCOLOGY INC$26.4M
AVTEAEROVATE THERAPEUTICS INC$23.1M
IDYAIDEAYA BIOSCIENCES INC$22.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CDTXCIDARA THERAPEUTICS INC$140.4M+208.0%
CTMXCYTOMX THERAPEUTICS INC$5.4M+166.1%
TSHATAYSHA GENE THERAPIES INC$39.3M+116.7%+182.7%
SLDBSOLID BIOSCIENCES INC$12.3M+34.2%
RNAMAVIDITY BIOSCIENCES INC$20.4M+15.3%
TYRATYRA BIOSCIENCES INC$17.8M+14.7%+220.0%
EWTXEDGEWISE THERAPEUTICS INC$-66.2M+11.2%+201.8%
GHRSGH RESEARCH PLC$17.0M+10.5%+121.6%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
TXG10X GENOMICS INC-CLASS A$-11.5M-75.6%
MBXMBX BIOSCIENCES INC$-6.8M-75.0%
TARAPROTARA THERAPEUTIC INC$-11.3M-69.4%
ACHCACADIA HEALTHCARE CO INC$-4.5M-58.9%
SRZNSURROZEN INC$-2.5M-11.3%
RYTMRHYTHM PHARMACEUTICALS INC$29.1M-8.6%+80.7%
AVTXAVALO THERAPEUTICS INC$-3.1M-3.5%
PCVXVAXCYTE INC$-71.3M-1.8%+79.6%
← Back to Hedge Funds